#ru58841

An androgen-responsive reporter construct was used to investigate the effect of RU58841, a nonsteroidal anti-androgen, on androgen receptor transcriptional activation in a human prostate cancer cell line.

RU-58841 is a nonsteroidal antiandrogen also known as PSK-3841 or HMR-3841. RU58841 is an anti-androgenic. This indicates that it blocks DHT's effects by binding to androgen receptors in hair follicles. As a result, DHT is unable to bind to these receptors.

RU-58841 is a novel anti-androgen that can suppress Androgen Receptor signaling. It was initially focused on potential applications in acne treatment, but it quickly became apparent that it could also use to treat pathological hair thinning. It is a targeted, localized therapy on the scalp with minimal systemic effects and DHT suppression for hair growth restoration.

Despite positive and persuasive study results demonstrating its success in stimulating hair regrowth in various hair loss models, RU58841 was abandoned. It caused a significant increase in hair density, thickness, and length when applied topically, but no systemic effects were seen.

You can Support your research with RU58841 SARM Powder. These improved hair growth rates indicate that topically applied RU58841 has a good effect on human hair growth from balding men grafted on to hairless mice, and these findings support a clinical trial to assess its potential in the treatment of androgen-dependent alopecia in adult men.

An androgen-responsive reporter constructs studied the effect of androgen receptor transcriptional activation by RU58841, a nonsteroidal anti-androgen, in the human prostate cancer cell line.